Neuland Laboratories Ltd (NEULANDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Neuland Laboratories Ltd (NEULANDLAB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH35537D
  • |
  • Pages: 26
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Neuland Laboratories Ltd (Neuland Lab), a subsidiary of Neuland Health Sciences Pvt Ltd is an API manufacturing service provider that manufactures active pharmaceutical ingredients, advanced intermediates; and offers chemistry related services. The company provides APIs in various therapeutic segments such as antibacterial, antialzheimer's, antihypertensive, antifungal, bronchodilator, antipsychotic, anesthetic, anticonvulsant, and others. It offers services such as contract manufacturing, contract API development, peptide synthesis, synthesis of chemical libraries, supply of clinical trial material, stability studies, and others. Neuland Lab has presence in Tokyo, Japan; and New Jersey, the US. The company operates two API manufacturing facilities close to the city of Hyderabad, Telangana. Neuland Lab is headquartered in Hyderabad, Telangana, India.

Neuland Laboratories Ltd (NEULANDLAB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 9

Asset Purchase 9

Neuland Lab Acquires Manufacturing Facility from Arch Pharmalabs 9

Equity Offering 10

Neuland Labs to Raise Funds through in Private Placement of Securities 10

Neuland Labs to Raise USD4 Million in Rights Offering of Shares 11

Neuland Labs Completes Rights Issue Of Shares For USD 2 Million 12

Neuland Laboratories Ltd-Key Competitors 13

Neuland Laboratories Ltd-Key Employees 14

Neuland Laboratories Ltd-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Joint Venture 15

Recent Developments 16

Strategy And Business Planning 16

Jul 20, 2017: Neuland Laboratories Unveils Dedicated Process Engineering Lab 16

Financial Announcements 17

May 11, 2018: Neuland Q4 FY18 income at Rs.1605.2 mn, PAT at Rs. 80.5 mn 17

Nov 22, 2017: Neuland Q2 FY18 income at Rs. 1,261.9mn 19

Sep 11, 2017: Neuland Q1 FY18 total income at Rs. 120.1 cr 20

May 12, 2017: Neuland Laboratories Reports Total RevenueOf INR5.7 Billion In Fiscal 2017 21

Corporate Communications 22

Nov 22, 2017: Appointment of Cheif Financial Officer 22

Aug 17, 2017: Neuland Laboratories Appoints Mr. D. Saharsh Rao as Chief Financial Officer 23

Feb 10, 2017: Neuland Laboratories Announces Resignation of Chief Financial Officer 24

Legal and Regulatory 25

Apr 08, 2017: Neuland Laboratories Update On US FDA Inspection at Bonthapally Manufacturing Facility 25

Appendix 26

Methodology 26

About GlobalData 26

Contact Us 26

Disclaimer 26

List of Figures

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

List of Tables

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Neuland Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8

Neuland Lab Acquires Manufacturing Facility from Arch Pharmalabs 9

Neuland Labs to Raise Funds through in Private Placement of Securities 10

Neuland Labs to Raise USD4 Million in Rights Offering of Shares 11

Neuland Labs Completes Rights Issue Of Shares For USD 2 Million 12

Neuland Laboratories Ltd, Key Competitors 13

Neuland Laboratories Ltd, Key Employees 14

Neuland Laboratories Ltd, Subsidiaries 15

Neuland Laboratories Ltd, Joint Venture 15

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Neuland Laboratories Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17743
Site License
USD 500 INR 35485
Corporate User License
USD 750 INR 53228

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com